Skip to content

Study · Randomized controlled trial · n = 46 · 2004

8 results

Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation.

Sonntag B, Kiesel L, Nieschlag E, Behre HM

Journal of assisted reproduction and genetics1 Jul 2004Cited by 4 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study8

8 results from studies that gave the peptide. 8 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In ovarian hyperstimulation patients, inhibin B before FSH stimulation was lower with triptorelin than with ganirelix.

    In plain wordsIn ovarian hyperstimulation patients, inhibin B before FSH stimulation was lower with triptorelin than with ganirelix.

    Outcome
    DecreaseInhibin B before FSH stimulation
    Study

    n = 46

    Comparator
    Ganirelix
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Inhibin B before FSH stimulation was significantly lower in group I than group II.
    1 context sentence
    Summary · context
    In a prospective randomized controlled trial, 46 patients undergoing COH received either triptorelin (group I, n = 15) or ganirelix (group II, n = 31).
  2. 02HumanRandomized controlled trialEfficacy outcome

    In ovarian hyperstimulation patients, FSH stimulation lasted longer with triptorelin than with ganirelix.

    In plain wordsIn ovarian hyperstimulation patients, FSH stimulation lasted longer with triptorelin than with ganirelix.

    Outcome
    IncreaseFSH stimulation duration
    Study

    n = 46

    Comparator
    Ganirelix
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The FSH stimulation phase was significantly longer in group I than group II, and the total FSH dose was significantly higher with a comparable number of retrieved oocytes.
    1 context sentence
    Summary · context
    In a prospective randomized controlled trial, 46 patients undergoing COH received either triptorelin (group I, n = 15) or ganirelix (group II, n = 31).
  3. 03HumanRandomized controlled trialEfficacy outcome

    In ovarian hyperstimulation patients, total FSH dose was higher with triptorelin than with ganirelix.

    In plain wordsIn ovarian hyperstimulation patients, total FSH dose was higher with triptorelin than with ganirelix.

    Outcome
    IncreaseTotal FSH dose
    Study

    n = 46

    Comparator
    Ganirelix
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The FSH stimulation phase was significantly longer in group I than group II, and the total FSH dose was significantly higher with a comparable number of retrieved oocytes.
    1 context sentence
    Summary · context
    In a prospective randomized controlled trial, 46 patients undergoing COH received either triptorelin (group I, n = 15) or ganirelix (group II, n = 31).
  4. 04HumanRandomized controlled trialEfficacy outcome

    In ovarian hyperstimulation patients, retrieved oocyte numbers were comparable with triptorelin and ganirelix.

    In plain wordsIn ovarian hyperstimulation patients, retrieved oocyte numbers were comparable with triptorelin and ganirelix.

    Outcome
    No significant changeRetrieved oocytes
    Study

    n = 46

    Comparator
    Ganirelix
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The FSH stimulation phase was significantly longer in group I than group II, and the total FSH dose was significantly higher with a comparable number of retrieved oocytes.
    1 context sentence
    Summary · context
    In a prospective randomized controlled trial, 46 patients undergoing COH received either triptorelin (group I, n = 15) or ganirelix (group II, n = 31).
  5. 05HumanRandomized controlled trialEfficacy outcome

    In patients undergoing ovarian hyperstimulation, inhibin B before FSH stimulation was significantly higher in the ganirelix group than in the triptorelin group.

    In plain wordsIn patients undergoing ovarian hyperstimulation, inhibin B before stimulation was significantly higher in the ganirelix group than in the triptorelin group.

    Peptide
    Ganirelix
    Outcome
    IncreaseInhibin B before FSH stimulation
    Study

    n = 46

    Comparator
    Triptorelin
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Inhibin B before FSH stimulation was significantly lower in group I than group II.
    1 context sentence
    Summary · context
    In a prospective randomized controlled trial, 46 patients undergoing COH received either triptorelin (group I, n = 15) or ganirelix (group II, n = 31).
  6. 06HumanRandomized controlled trialEfficacy outcome

    In patients undergoing ovarian hyperstimulation, the FSH stimulation phase was significantly shorter with ganirelix than triptorelin.

    In plain wordsIn patients undergoing ovarian hyperstimulation, FSH stimulation was shorter with ganirelix than triptorelin.

    Peptide
    Ganirelix
    Outcome
    DecreaseFSH stimulation duration
    Study

    n = 46

    Comparator
    Triptorelin
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The FSH stimulation phase was significantly longer in group I than group II, and the total FSH dose was significantly higher with a comparable number of retrieved oocytes.
    1 context sentence
    Summary · context
    In a prospective randomized controlled trial, 46 patients undergoing COH received either triptorelin (group I, n = 15) or ganirelix (group II, n = 31).
  7. 07HumanRandomized controlled trialEfficacy outcome

    In patients undergoing ovarian hyperstimulation, total FSH dose was significantly lower with ganirelix than triptorelin.

    In plain wordsIn patients undergoing ovarian hyperstimulation, total FSH dose was lower with ganirelix than triptorelin.

    Peptide
    Ganirelix
    Outcome
    DecreaseTotal FSH dose
    Study

    n = 46

    Comparator
    Triptorelin
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The FSH stimulation phase was significantly longer in group I than group II, and the total FSH dose was significantly higher with a comparable number of retrieved oocytes.
    1 context sentence
    Summary · context
    In a prospective randomized controlled trial, 46 patients undergoing COH received either triptorelin (group I, n = 15) or ganirelix (group II, n = 31).
  8. 08HumanRandomized controlled trialEfficacy outcome

    In patients undergoing ovarian hyperstimulation, retrieved oocyte numbers were comparable with ganirelix and triptorelin.

    In plain wordsIn patients undergoing ovarian hyperstimulation, retrieved egg numbers were comparable with ganirelix and triptorelin.

    Peptide
    Ganirelix
    Outcome
    Direction not reportedRetrieved oocyte number
    Study

    n = 46

    Comparator
    Triptorelin
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The FSH stimulation phase was significantly longer in group I than group II, and the total FSH dose was significantly higher with a comparable number of retrieved oocytes.
    1 context sentence
    Summary · context
    In a prospective randomized controlled trial, 46 patients undergoing COH received either triptorelin (group I, n = 15) or ganirelix (group II, n = 31).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    27 Oct 2026, 16:35 UTC

    Study data updated · source update from Europe PMC

  2. Version 2

    22 Oct 2026, 02:26 UTC

    Study results updated

  3. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.